Wendy J. C. Prager‐van der Smissen

Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration

Marcel Smid, F. Germán Rodríguez-González, Anieta M. Sieuwerts et al. · Nature Communications · 2016 · 113 citations · Full text

The circular RNome of primary breast cancer

Marcel Smid, Saskia M. Wilting, Katharina Uhr et al. · Genome Research · 2019 · 108 citations · Full text

MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines

Katharina Uhr, Wendy J. C. Prager‐van der Smissen, Anouk A. J. Heine et al. · PLoS ONE · 2019 · 64 citations · Full text

Breast Oncology, Intrinsic Drug Resistance, Pathology +18

CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes

Bianca Mostert, Jaco Kraan, Anieta M. Sieuwerts et al. · Cancer Letters · 2011 · 50 citations

Breast Oncology, Oncology, Cancer Immunosurveillance +11

GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease

Jingjing Liu, Wendy J. C. Prager‐van der Smissen, Maxime P. Look et al. · Cancer Letters · 2016 · 26 citations · Full text